Guardant Health [GH] vs Qiagen N.V [QGEN] Detailed Stock Comparison

Guardant Health

NASDAQ
Loading...

Qiagen N.V

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Guardant Health wins in 7 metrics, Qiagen N.V wins in 11 metrics, with 0 ties. Qiagen N.V appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGuardant HealthQiagen N.VBetter
P/E Ratio (TTM)-17.4526.03Guardant Health
Price-to-Book Ratio-25.242.72Guardant Health
Debt-to-Equity Ratio-4.3742.31Guardant Health
PEG Ratio3.66-0.17Qiagen N.V
EV/EBITDA-20.3810.08Guardant Health
Profit Margin (TTM)-49.93%18.30%Qiagen N.V
Operating Margin (TTM)-45.75%25.49%Qiagen N.V
EBITDA Margin (TTM)N/A25.49%N/A
Return on Equity312.48%10.81%Guardant Health
Return on Assets (TTM)-19.57%9.01%Qiagen N.V
Free Cash Flow (TTM)$-274.94M$502.31MQiagen N.V
1-Year Return177.35%6.13%Guardant Health
Price-to-Sales Ratio (TTM)9.334.68Qiagen N.V
Enterprise Value$8.54B$10.06BQiagen N.V
EV/Revenue Ratio10.314.93Qiagen N.V
Gross Profit Margin (TTM)65.01%62.65%Guardant Health
Revenue per Share (TTM)$7$9Qiagen N.V
Earnings per Share (Diluted)$-3.46$1.69Qiagen N.V
Beta (Stock Volatility)1.460.64Qiagen N.V
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Guardant Health vs Qiagen N.V Stock Performance Analysis

Loading Price Chart...

Guardant Health
Qiagen N.V
Guardant Health Stock Overview | Qiagen N.V Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Guardant Health-1.90%2.13%-7.59%22.48%41.32%93.45%
Qiagen N.V-0.17%5.26%-1.45%-4.93%15.54%3.86%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Guardant Health177.35%10.24%-43.19%110.48%110.48%110.48%
Qiagen N.V6.13%8.77%-15.53%71.77%159.63%235.07%

News Based Sentiment: Guardant Health vs Qiagen N.V

Guardant Health

News based Sentiment: POSITIVE

Guardant Health delivered a strong Q2 performance with revenue exceeding expectations and raised full-year guidance. A significant legal victory and key partnerships further bolster the company's position, though continued cash burn remains a concern. These developments suggest a positive trajectory for the company, making October a significant month for investors.

View Guardant Health News Sentiment Analysis

Qiagen N.V

News based Sentiment: POSITIVE

Qiagen demonstrated resilience in a down market, secured a key partnership expansion in Japan, received an analyst upgrade, and benefits from a strong growth forecast in the cancer biomarkers market. These factors collectively suggest a positive outlook for the company, though valuation remains fair.

View Qiagen N.V News Sentiment Analysis

Performance & Financial Health Analysis: Guardant Health vs Qiagen N.V

MetricGHQGEN
Market Information
Market Cap i$7.73B$9.69B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i2,782,0301,123,284
90 Day Avg. Volume i2,486,5871,273,311
Last Close$61.46$46.24
52 Week Range$20.14 - $68.00$37.63 - $51.88
% from 52W High-9.62%-10.87%
All-Time High$181.07 (Feb 08, 2021)$60.81 (Jul 17, 2000)
% from All-Time High-66.06%-23.96%
Growth Metrics
Quarterly Revenue Growth0.31%0.08%
Quarterly Earnings Growth0.31%0.07%
Financial Health
Profit Margin (TTM) i-0.50%0.18%
Operating Margin (TTM) i-0.46%0.25%
Return on Equity (TTM) i3.12%0.11%
Debt to Equity (MRQ) i-4.3742.31
Cash & Liquidity
Book Value per Share (MRQ)$-2.45$16.17
Cash per Share (MRQ)$4.19$4.40
Operating Cash Flow (TTM) i$-238,546,000$675.03M
Levered Free Cash Flow (TTM) i$-131,174,000$683.15M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Guardant Health vs Qiagen N.V

MetricGHQGEN
Price Ratios
P/E Ratio (TTM) i-17.4526.03
Forward P/E i-22.8719.21
PEG Ratio i3.66-0.17
Price to Sales (TTM) i9.334.68
Price to Book (MRQ) i-25.242.72
Market Capitalization
Market Capitalization i$7.73B$9.69B
Enterprise Value i$8.54B$10.06B
Enterprise Value Metrics
Enterprise to Revenue i10.314.93
Enterprise to EBITDA i-20.3810.08
Risk & Other Metrics
Beta i1.460.64
Book Value per Share (MRQ) i$-2.45$16.17

Financial Statements Comparison: Guardant Health vs Qiagen N.V

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GHQGEN
Revenue/Sales i$203.47M$533.54M
Cost of Goods Sold i$74.72M$199.25M
Gross Profit i$128.75M$334.29M
Research & Development i$88.52M$47.75M
Operating Income (EBIT) i$-111.04M$135.97M
EBITDA i$-83.84M$200.58M
Pre-Tax Income i$-94.87M$126.82M
Income Tax i$290,000$30.57M
Net Income (Profit) i$-95.16M$96.25M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GHQGEN
Cash & Equivalents i$698.57M$638.76M
Total Current Assets i$927.03M$1.74B
Total Current Liabilities i$225.75M$516.94M
Long-Term Debt i$1.28B$1.35B
Total Shareholders Equity i$-250.79M$3.41B
Retained Earnings i$-2.67B$2.50B
Property, Plant & Equipment i$140.50MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GHQGEN
Operating Cash Flow i$-49.41M$190.30M
Capital Expenditures i$-4.46M$-43.90M
Free Cash Flow i$-67.15M$95.48M
Debt Repayment iN/AN/A
Common Stock Repurchase i$-45.01MN/A

Short Interest & Institutional Ownership Analysis

MetricGHQGEN
Shares Short i8.74M6.67M
Short Ratio i3.674.93
Short % of Float i0.07%0.05%
Average Daily Volume (10 Day) i2,782,0301,123,284
Average Daily Volume (90 Day) i2,486,5871,273,311
Shares Outstanding i123.99M216.12M
Float Shares i119.85M214.89M
% Held by Insiders i0.04%0.02%
% Held by Institutions i0.99%0.89%

Dividend Analysis & Yield Comparison: Guardant Health vs Qiagen N.V

MetricGHQGEN
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.44
3-Year Avg Dividend Yield iN/A3.03%
3-Year Total Dividends iN/A$1.32
Ex-Dividend DateN/AJan 30, 2024